Format
Sort by

Send to:

Choose Destination

Search results

Items: 5

1.

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.

Svoboda M, Sana J, Fabian P, Kocakova I, Gombosova J, Nekvindova J, Radova L, Vyzula R, Slaby O.

Radiat Oncol. 2012 Nov 20;7:195. doi: 10.1186/1748-717X-7-195.

2.

Novel classes of non-coding RNAs and cancer.

Sana J, Faltejskova P, Svoboda M, Slaby O.

J Transl Med. 2012 May 21;10:103. doi: 10.1186/1479-5876-10-103. Review.

3.

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.

Svoboda M, Sana J, Redova M, Navratil J, Palacova M, Fabian P, Slaby O, Vyzula R.

Diagn Pathol. 2012 Mar 22;7:31. doi: 10.1186/1746-1596-7-31.

4.

CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines.

Sana J, Zambo I, Skoda J, Neradil J, Chlapek P, Hermanova M, Mudry P, Vasikova A, Zitterbart K, Hampl A, Sterba J, Veselska R.

Anal Cell Pathol (Amst). 2011;34(6):303-18. doi: 10.3233/ACP-2011-0018.

5.

MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications.

Sana J, Hajduch M, Michalek J, Vyzula R, Slaby O.

J Cell Mol Med. 2011 Aug;15(8):1636-44. doi: 10.1111/j.1582-4934.2011.01317.x. Review.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk